solanaceae began at the end of last year , the institute of cytology and genetics of the siberian department of wounds was involved in research, scientists of akademgorodok received two weakened headquarters virus. this became the basis for the future drug explains academician alexei kochetov so far. we didn't work. uh, with plant viruses in terms of creating the final product. that is, we worked, of course, we evaluated the virus resistance of different plants with certain altered genes. it was a variant of research, that is, to understand. e, if e such and such an allergen provides resistance to the virus. it's uh, good. action markers can be developed on it. fitov, vaccines similar to the work of drugs for humans or animals plants receive a weakened virus. after that, a person who has been ill with a mild strain of tomato will no longer become infected with a severe one; he will have immunity. a mild form means that nu does not lose its qualities. e commodity e, plant productivity activate the mechanisms of rna interference. these are just natural mechanisms and create special hmm uh, special forms